Mamas Mamas to Platelet Aggregation Inhibitors
This is a "connection" page, showing publications Mamas Mamas has written about Platelet Aggregation Inhibitors.
Connection Strength
0.860
-
Antiplatelet drug selection in PCI to vein grafts in patients with acute coronary syndrome and adverse clinical outcomes: Insights from the British Cardiovascular Intervention Society database. Catheter Cardiovasc Interv. 2018 10 01; 92(4):659-665.
Score: 0.330
-
Cancer Event Rate and Mortality with Thienopyridines: A Systematic Review and Meta-Analysis. Drug Saf. 2017 03; 40(3):229-240.
Score: 0.310
-
Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis. BMJ. 2019 Oct 10; 367:l5476.
Score: 0.093
-
Effect of Antiplatelet Therapy (Aspirin + Dipyridamole Versus Clopidogrel) on Mortality Outcome in Ischemic Stroke. Am J Cardiol. 2018 09 15; 122(6):1085-1090.
Score: 0.086
-
Association of different antiplatelet therapies with mortality after primary percutaneous coronary intervention. Heart. 2018 10; 104(20):1683-1690.
Score: 0.021
-
Retroperitoneal Hemorrhage After Percutaneous Coronary Intervention: Incidence, Determinants, and Outcomes as Recorded by the British Cardiovascular Intervention Society. Circ Cardiovasc Interv. 2018 02; 11(2):e005866.
Score: 0.021